Sp362

ESOPHAGEAL AND GASTRIC CONDITIONS AND SPECIAL SCREENING IN AT RISK POPULATIONS

Date
May 19, 2024

Presenter

Speaker Image for Prasad Iyer
Mayo Clinic

Tracks

Related Products

Thumbnail for AI Beyond the Endoscope: How AI is Revolutionizing GI Practice
AI Beyond the Endoscope: How AI is Revolutionizing GI Practice
This session looks at the rapidly growing applications and impacts of AI beyond endoscopy in the GI world, including office tools, scribes, billing resources, EHR tools etc…
Thumbnail for VALIDATION OF COPY NUMBER ABERRATION AND METHYLATED DNA MARKERS FOR DIFFERENTIATION OF NON-DYSPLASTIC BARRETT’S ESOPHAGUS FROM BARRETT’S ESOPHAGUS WITH HIGH GRADE DYSPLASIA AND ESOPHAGEAL ADENOCARCINOMA : A MULTICENTER STUDY
VALIDATION OF COPY NUMBER ABERRATION AND METHYLATED DNA MARKERS FOR DIFFERENTIATION OF NON-DYSPLASTIC BARRETT’S ESOPHAGUS FROM BARRETT’S ESOPHAGUS WITH HIGH GRADE DYSPLASIA AND ESOPHAGEAL ADENOCARCINOMA : A MULTICENTER STUDY
Endoscopic surveillance of Barrett’s esophagus (BE) is recommended to identify dysplasia (low grade [LGD], high grade [HGD]) or adenocarcinoma [EAC]) for endoscopic intervention. However, this paradigm is limited by sampling error and subtle endoscopic changes, leading to missed HGD and EAC…